130 likes | 236 Views
Methods of analysing healthcare costs in l ung c ancer CT-screening. Does lung cancer CT screening lead to more healthcare use ?. Healthcare costs in 12 months. Healthcare costs in 12 months. Healthcare costs in 12 months. Groups analysed:.
E N D
Jakob Fraes Rasmussen, jakobra@sund.ku.dk Methods of analysing healthcare costs in lung cancer CT-screening
Jakob Fraes Rasmussen, jakobra@sund.ku.dk Doeslung cancer CT screening lead to more healthcareuse?
Jakob Fraes Rasmussen, jakobra@sund.ku.dk Healthcare costs in 12 months Healthcare costs in 12 months Healthcare costs in 12 months
Jakob Fraes Rasmussen, jakobra@sund.ku.dk Groups analysed:
Jakob Fraes Rasmussen, jakobra@sund.ku.dk Prevalence of healthcareuse in the diagnosticgroupscompared with the controlgroup GP = General Practitioner
Jakob Fraes Rasmussen, jakobra@sund.ku.dk The quantity of healthcare use in the diagnostic groups compared with the control group GP = General Practitioner
Jakob Fraes Rasmussen, jakobra@sund.ku.dk Prevalence Quantity Cumulative Effect GP = General Practitioner
Jakob Fraes Rasmussen, jakobra@sund.ku.dk Mean annual healthcare costs per participant in the control group and the diagnostic groups in the DLCST during five screening rounds
Jakob Fraes Rasmussen, jakobra@sund.ku.dk • NLST: Aberle DR et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365(5):395-409. • NELSON: van Klaveren RJ et al. Management of lungnodulesdetected by volume CT scanning. N Engl J Med 2009; 361(23):2221-2229. • DLCST: Saghir Z et al. CT screening for lung cancer brings forward early disease. • The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012; 67(4):296-301.